Table I.
Demographics and clinical measurements in the two groups.
| Characteristics | RVO (n=24) | HC (n=24) | T | P-value |
|---|---|---|---|---|
| Males/females | 12/12 | 12/12 | N/A | >0.99 |
| Age (years) | 54.04±4.93 | 56.76±5.87 | 0.097 | 0.753 |
| Body weight (kg) | 66.46±6.12 | 68.11±5.98 | 0.154 | 0.916 |
| Right-handedness | 24 | 24 | N/A | >0.99 |
| Duration of RVO (days) | 66.67±24.28 | N/A | N/A | N/A |
| Best-corrected VA | ||||
| Right eye | 0.16±0.07 | 0.95±0.12 | −0.432 | 0.001 |
| Left eye | 0.22±0.10 | 0.98±0.22 | −0.396 | 0.001 |
| IOP (mmHg) | ||||
| Right eye | 14.69±1.11 | 16.54±1.23 | 0.078 | 0.673 |
| Left eye | 14.62±0.99 | 15.18±2.32 | 0.085 | 0.731 |
| Central subfield retinal thickness (µm) | 701.13±81.61 | 301.58±46.18 | 0.683 | 0.012 |
| Cube average thickness (µm) | 746.83±86.67 | 312.34±44.52 | 0.531 | 0.009 |
VA, visual acuity; RVO, retinal vein occlusion; HC, healthy controls; N/A, not applicable; IOP, intraocular pressure.